HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of infliximab in long-lasting refractory Kawasaki disease.

AuthorsF Zulian, G Zanon, G Martini, G Mescoli, O Milanesi
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2006 Jul-Aug Vol. 24 Issue 4 Pg. 453 ISSN: 0392-856X [Print] Italy
PMID16956440 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Warfarin
  • Infliximab
  • Aspirin
Topics
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Aspirin (therapeutic use)
  • Child, Preschool
  • Drug Resistance
  • Drug Therapy, Combination
  • Humans
  • Infliximab
  • Injections, Intravenous
  • Male
  • Mucocutaneous Lymph Node Syndrome (drug therapy)
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (therapeutic use)
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: